Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
July 2022
in “
Journal of Medicinal Chemistry
”
Studysummary This article discusses the potential for combining PROTACs with other therapeutic modalities in drug discovery and reports no clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on cris.unibo.it →